Mostrando 2 resultados de: 2
A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: A new strategy for heart failure diagnostics and therapeutics
ArticleAbstract: Aims Ongoing inflammation and endothelial dysfunction occurs within the local microenvironment of hePalabras claves:cardiomyopathy, Heart Failure, Nanoconstructs, Nanomedicine, Nanoparticles, nanotechnologyAutores:Amione-Guerra J., Andrea M. Cordero-Reyes, Blanco E., Cara F.E., Cruz-Solbes A.S., Ferrari M., Flores-Arredondo J.H., García-Rivas G., Guerrero-Beltrán C.E.n., Kirui D.K., Paez-Mayorga J., Ruiz-Esparza G.U., Segura-Ibarra V., Serda R.E., Torre-Amione G., Yokoi K., Youker K.A.Fuentes:scopusFull expression of cardiomyopathy is partly dependent on B-cells: A pathway that involves cytokine activation, immunoglobulin deposition, and activation of apoptosis
ArticleAbstract: Background-Limited information exists on the role of B-cell-dependent mechanisms in the progressionPalabras claves:Antibodies, cardiomyopathy, Immune system, Lymphocytes, remodelingAutores:Andrea M. Cordero-Reyes, Bhimaraj A., Celis R., Estep J.D., Flores-Arredondo J.H., Hamilton D.J., Orrego C.M., Torre-Amione G., Trevino A.R., Youker K.A.Fuentes:scopus